TP53 and neoplasm: The TP53 positive tumors in NGS had at least one pathogenic/likely pathogenic alteration in the p53 DBD, of which three (75 %) exhibited the previously reported alteration TP53 c.751A>C (p.Ile251Leu) with a low allele frequency (<0.05, expected for a somatic variant) in tumor DNA.